Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Scardino
    Scardino
  5. Eastham
    Eastham
  6. Jarnagin
    Jarnagin
  7. Reuter
    Reuter
  8. D'Angelica
    D'Angelica
  9. Kingham
    Kingham
  10. Ladanyi
    Ladanyi

Groups

  1. Surgery (2075)
  2. Department of Medicine (1355)
  3. Urology (1171)
  4. Solid Tumor Oncology Division (842)
  5. Population Sciences Research Program (830)
  6. Survivorship Research (727)
  7. Epidemiology and Biostatistics (694)
  8. Sloan Kettering Institute Faculty (603)
  9. Department of Pathology and Laboratory Medicine (594)
  10. GSK Faculty (585)
Search Within
Formats
  1. Journal Article (3921)
  2. Meeting Abstract (1056)
  3. Editorial (181)
  4. Review (142)
  5. Correspondence (121)
  6. Guidelines (83)
  7. Research Letter (33)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2075)
  2. Department of Medicine (1355)
  3. Urology (1171)
  4. Solid Tumor Oncology Division (842)
  5. Population Sciences Research Program (830)
  6. Survivorship Research (727)

More Groups

People
  1. Harry Herr (271)
  2. Andrew Vickers (229)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (163)
  6. William Jarnagin (159)

More People

Years
  1. 2025 (167)
  2. 2024 (255)
  3. 2023 (235)
  4. 2022 (263)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (768)
  2. European Urology (580)
  3. Lancet Oncology (405)
  4. Urology (392)
  5. Journal of the American College of Surgeons (348)
  6. Journal of Molecular Diagnostics (277)

More Publications

Results (5572)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): An international, phase 2 study
    Journal Article

    Li, B. T.; Meric-Bernstam, F.; Bardia, A.; Naito, Y.; Siena, S.; Aftimos, P.; Anderson, I.; Curigliano, G.; de Miguel, M.; Kalra, M.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): A single-arm, multicentre, phase 2 trial
    Journal Article

    Necchi, A.; Roumiguié, M.; Kamat, A. M.; Shore, N. D.; Boormans, J. L.; Esen, A. A.; Lebret, T.; Kandori, S.; Bajorin, D. F.; Krieger, L. E. M.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
    Review

    Lapi, S. E.; Scott, P. J. H.; Scott, A. M.; Windhorst, A. D.; Zeglis, B. M.; Abdel-Wahab, M.; Baum, R. P.; Buatti, J. M.; Giammarile, F.; Kiess, A. P.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Immune effector cell-associated haematotoxicity after CAR T-cell therapy: From mechanism to management
    Review

    Rejeski, K.; Jain, M. D.; Shah, N. N.; Perales, M. A.; Subklewe, M.
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
    Guidelines

    Rodriguez-Otero, P.; Usmani, S.; Cohen, A. D.; van de Donk, N. W. C. J.; Leleu, X.; Gállego Pérez-Larraya, J.; Manier, S.; Nooka, A. K.; Mateos, M. V.; Einsele, H.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • The Lancet Breast Cancer Commission
    Review

    Coles, C. E.; Earl, H.; Anderson, B. O.; Barrios, C. H.; Bienz, M.; Bliss, J. M.; Cameron, D. A.; Cardoso, F.; Cui, W.; Francis, P. A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Intranodal lymphangiography and embolization for management of iatrogenic chylous ascites after oncological surgery
    Journal Article

    Aly, A. K.; Santos, E.; Fung, J.; Maybody, M.; Youssef, E. W.; Petre, E. N.; Gonzalez-Aguirre, A. J.; Moussa, A. M.
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® female breast cancer screening: 2023 update
    Guidelines

    Niell, B. L.; Jochelson, M. S.; Amir, T.; Brown, A.; Adamson, M.; Baron, P.; Bennett, D. L.; Chetlen, A.; Dayaratna, S.; Freer, P. E.; more...
    Journal of the American College of Radiology (2024)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® hydronephrosis on prior imaging-unknown cause
    Guidelines

    Whitworth, P. 3rd; Courtney, K. G.; Oto, A.; Allen, B. C.; Akin, O.; Barker, S. J.; Bartel, T. B.; DuBeau, C.; Gerena, M.; Kraft, K. H.; more...
    Journal of the American College of Radiology (2024)

    Fulltext@MSK | Save
  • Patient factors associated with cancer worry post-breast reconstruction: A cross-sectional study
    Journal Article

    Gallo, L.; Kaur, M.; Tsangaris, E.; Griffith, L.; Nelson, J. A.; Pusic, A. L.; Klassen, A. F.; Voineskos, S.
    Journal of Plastic Reconstructive and Aesthetic Surgery (2024)

    Fulltext@MSK | Save